Z-1474-2026 Class II Ongoing

Recalled by Remel, Inc — Lenexa, KS

FDA device recall Z-1474-2026 was initiated by Remel, Inc on February 5, 2026 and is designated Class II. Reason for recall: Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium. The recall status is ongoing. Affected quantity: 97.

Recall Details

Product Type
Devices
Report Date
March 4, 2026
Initiation Date
February 5, 2026
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
97

Product Description

Campy CVA Medium 100/PK, R01272

Reason for Recall

Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium.

Distribution Pattern

US Nationwide distribution in the states of AZ, CO, IL, NJ, OH, TN, WA.

Code Information

UDI-DI 848838001055 Lot R01272 lot 339135 Expired January 12, 2026